1. Introduction {#sec0005}
===============

Hydrogen peroxide (H~2~O~2~), which is one of the reactive oxygen species (ROS), induces oxidative stress in living organisms and is involved in a variety of signaling pathways \[[@bib0005], [@bib0010], [@bib0015], [@bib0020]\]. Antioxidants and antioxidant enzymes in blood and cells remove H~2~O~2~ and minimize the concentration to suppress the oxidative stress. The autoxidation of hemoglobin in erythrocytes is generated by H~2~O~2~ in plasma or blood removed by the erythrocytes. As the H~2~O~2~-scavenging activity of glutathione peroxidase and peroxiredoxin 2 in erythrocytes is reportedly low \[[@bib0025],[@bib0030]\], it is deduced that the catalase \[EC1.11.1.6\] that is present in erythrocytes is important in the defense against oxidative stress. In 1948, hereditary catalase deficiency, named "acatalasemia" was reported by Takahara et al. \[[@bib0035],[@bib0040]\]. People with acatalasemia suffer from progressive oral gangrene and ulceration. The disease was later called Takahara's disease, and the authors suggested that the disease is induced by infection with H~2~O~2~--generating bacteria. During the late 1940s and early 1950s (after the war), oral hygiene in Japan was poor and the disease was present in approximately one half of the acatalasemic cases tested \[[@bib0045], [@bib0050], [@bib0055]\]. However, the disease is rarely found in Japan at present, with only a small number reported in China \[[@bib0060]\]. In 1961, Aebi reported cases of acatalasemia in Switzerland \[[@bib0065]\], and in 1992 Goth reported cases in Hungary \[[@bib0070]\]. The residual catalase activity of acatalasemic erythrocytes in Switzerland and Hungary was found to be higher than in Japan, and there has been no report of Takahara's disease. The gene frequency of acatalasemia in Japan, Switzerland and Hungary is estimated to be 0.08/1000, 0.05/1000 and 0.04/1000, respectively \[[@bib0055]\]. In 2000, Goth suggested that acatalasemia patients in Hungary were at a higher risk for and an earlier manifestation of diabetes (10 years) \[[@bib0075]\]. Animal experiments indicated that low catalase activity in blood is associated with mouse diabetes under oxidative stress conditions \[[@bib0080]\]. The oxidative stress damaged oxidant-sensitive beta cells in the pancreas and thereby induced diabetes, and the beta cell damage was shown to be ameliorated by antioxidants \[[@bib0085], [@bib0090], [@bib0095]\].

In terms of Takahara's disease in acatalasemic patients, it is suggested that the disease is associated with the level of residual catalase activity in erythrocytes, but the specific relationship between the disease and the residual activity level is unclear. Ogata et al. showed that methemoglobin formation is higher in acatalasemic erythrocytes than normal ones \[[@bib0100]\]. We reported that the H~2~O~2~ scavenging activity of oxidized hemoglobin is as high as the residual catalase activity in acatalasemic mouse erythrocytes \[[@bib0105], [@bib0110], [@bib0115], [@bib0120]\]. When supra-physiological H~2~O~2~ was added to acatalasemic mouse erythrocytes, hemolysis (0.1 mM H~2~O~2~) and hydrolysis-resistant erythrocytes (1 mM) were observed \[[@bib0125]\]. As hydrolysis-resistant erythrocytes cause impaired oxygen transport and other circulatory disturbances, we suggest that these erythrocytes are related to the disease. However, it was recently reported that normal, acatalasemic-like human erythrocytes treated with sodium azide were prepared, and hydrolysis-resistant erythrocytes were generated by a lower concentration of H~2~O~2~ than that needed for hemolysis \[[@bib0130],[@bib0135]\]. We examined oxidative damage in H~2~O~2~-treated mouse erythrocytes.

2. Materials and methods {#sec0010}
========================

2.1. Animals and chemicals {#sec0015}
--------------------------

The acatalasemic (C3H/AnLC~S~^b^C~S~^b^) and normal (C3H/AnLC~S~^a^C~S~^a^) mouse strains established by Feinstein et al. \[[@bib0140]\] were used in this study. A genetic defect has been reported \[[@bib0145],[@bib0150]\], and is no report of Takahara's disease in mice. Mice were maintained on a Laboratory diet (the CE-2 diet, Clea Japan, Tokyo, Japan) and water *ad libitum* until they were 12 weeks old. All of the animal procedures were carried out in accordance with the Guide for the Care and Use of Laboratory Animals as published by the Japanese Association for Laboratory Animal Science. All experiments were approved by the Ethics Review Committees for Animal Experimentation at Okayama University of Science. Alcian blue 8GX, 30 % H~2~O~2~ and other reagents were purchased from Wako Pure Chemical Industries (Osaka, Japan) and were of analytical grade. H~2~O~2~ solution was diluted with physiological saline containing 10 mM potassium phosphate buffer (PBS, pH 7.4), and 100 mM H~2~O~2~ (stock solution) were prepared. The concentration of H~2~O~2~ was checked using 0.01 M sodium thiosulfate solution. Catalase activity was measured according to a previously reported method \[[@bib0105],[@bib0110]\]. Hemoglobin content was determined by the method of Drabkin and Austin \[[@bib0155]\], and the concentrations of hemoglobin indicated were calculated as a tetramer. Alcian-blue 8GX 400 mg was dissolved in 100 ml of PBS, and the mixture was centrifuged at 2000 X g for 10 min. The supernatant was diluted 32 times with PBS, and the solution was used as the alcian blue solution \[[@bib0160]\]. Neuraminidase (sialidase, EC 3.2.1.18) was purchased from Nakalai Tesque (Kyoto, Japan) and diluted with PBS (pH 8.0). SDS-PAGE was performed according to the method of Laemmli \[[@bib0165]\].

2.2. Preparation of packed erythrocytes {#sec0020}
---------------------------------------

Mouse blood was collected by cardiac puncture, and heparin was used as an anticoagulant. Erythrocytes were separated and washed three times with PBS pH7.4 after centrifugation at 1600 X g for 10 min. Packed erythrocytes were stored at 4 °C and used immediately.

2.3. Hydrolysis-resistant erythrocytes among the erythrocytes treated with H~2~O~2~ {#sec0025}
-----------------------------------------------------------------------------------

The hydrolysis-resistant erythrocytes was examined as follows. Packed erythrocytes (0.06 mL) were diluted with 2.94 ml of PBS or PBS containing H~2~O~2~ (at a final concentration of 0.1, 1.0 or 5.0 mM), and the mixture was incubated at 37 °C for 5 min. The incubation mixture (0.06 mL) was diluted with 50 volumes of water. After centrifugation, the absorbance of the supernatant at 540 nm was recorded. The amount of hydrolysis-resistant erythrocytes was calculated using the absorbance (100 % hemolysis) obtained from the addition of water to the 2 % suspension. A two percent erythrocyte suspension containing 5 mM H~2~O~2~ and 50 μM α-tocopherol was prepared and tested as described above.

2.4. Hemolysis of mouse erythrocytes induced by H~2~O~2~ {#sec0030}
--------------------------------------------------------

Packed erythrocytes (0.06 mL) were diluted with 2.94 ml of PBS or PBS containing H~2~O~2~, and the mixture incubated at 37 °C for 30 min. After centrifugation, the absorbance of the supernatant at 540 nm was recorded \[[@bib0125]\].

2.5. Osmotic fragility of H~2~O~2~-treated erythrocytes {#sec0035}
-------------------------------------------------------

The hemolysis of H~2~O~2~-treated erythrocytes was examined using NaCl aqueous solution \[[@bib0170]\]. Packed erythrocytes were diluted to a 2 % erythrocyte suspension (v/v) with PBS containing 0.0, 0.1, 1 or 5 mM H~2~O~2~, and the mixture was reacted at 37 °C for 5 min. Each portion (0.06 mL) was added to 2.94 ml of water or 0.40, 0.60, 0.70 and 0.90 % NaCl in water, respectively, and the mixture was incubated at 37 °C for 30 min. After centrifugation (1,600 X g for 10 min), the absorbance of the supernatant at 540 nm was recorded. Absorbance of 100 % hemolysis was obtained from the addition of water to each erythrocyte suspension treated with H~2~O~2,~ and the NaCl concentration at 50 % hemolysis was interpolated from the recorded values.

2.6. Preparation of 1 mM H~2~O~2~-treated erythrocytes {#sec0040}
------------------------------------------------------

Packed erythrocytes (0.03 mL) were diluted with PBS containing a 1 mM H~2~O~2~ (1.47 mL) to 2 % erythrocyte ratio in suspension. The suspension was incubated at 37 °C for 5 min, and the erythrocytes were washed 3 times with PBS. After centrifugation, the packed erythrocytes were used as 1 mM H~2~O~2~-treated erythrocytes.

2.7. Sialic acid release from mouse erythrocytes by sialidase treatment {#sec0045}
-----------------------------------------------------------------------

As the negative charge of erythrocytes is associated with sialic acid content, the sialic acid released by sialidase was measured \[[@bib0175]\].

Packed erythrocytes or 1 mM H~2~O~2~-treated erythrocytes (0.03 mL) were diluted with 1.47 ml of PBS containing sialidase (1 unit/ mL). Each suspension was incubated at 37 °C for 30 min. The supernatant was separated by centrifugation and was stored at -80 °C until measurement. The sialic acid determination was carried out using a spectrophotometric assay kit (BioVision Inc., USA) according to the manufacturer's suggested procedure, and the absorbance at 570 nm was recorded. The packed erythrocytes were used as sialidase-treated erythrocytes for the following experiment.

2.8. Effect of 1 mM H~2~O~2~ on alcian blue binding to erythrocytes and sialidase-treated erythrocytes {#sec0050}
------------------------------------------------------------------------------------------------------

The negative charge on the erythrocytes was evaluated using the alcian blue binding method.

The packed erythrocytes or sialidase-treated erythrocytes were diluted with PBS (1.47 mL) or PBS containing 1 mM H~2~O~2~, and the mixture was reacted at 37 °C for 5 min. After centrifugation, the erythrocytes were diluted with PBS to 1.0 × 10^5^ erythrocytes / μL. Nine volumes of alcian blue solution were added to each suspension. The mixture was reacted at 37 °C for 30 min. After centrifugation (800 X g for 10 min), absorbance of the supernatant at 650 nm was recorded to determine the unbound alcian blue. Evaluation of the negative charge was carried out using a reported method \[[@bib0180]\].

2.9. Membrane-flickering erythrocytes after H~2~O~2~ treatment {#sec0055}
--------------------------------------------------------------

The vibrating erythrocytes were counted under microscopy \[[@bib0185]\].

Packed erythrocytes (0.03 mL) or 1 mM H~2~O~2~-treated erythrocytes were diluted with 400 volumes of PBS, and all of the erythrocytes as well as the flickering ones were counted with a Thoma blood counter. The percentage of the flickering erythrocytes was calculated as (vibrating erythrocytes / total erythrocytes) X 100.

2.10. SDS-PAGE Analysis of membrane proteins in H~2~O~2~-treated erythrocytes {#sec0060}
-----------------------------------------------------------------------------

As SDS-PAGE of H~2~O~2~-treated mouse erythrocytes has been reported in \[[@bib0125]\], SDS-PAGE of membrane proteins in the erythrocytes were examined.

Three ml of PBS or 0.1, 0.5, 1.0 and 5.0 mM H~2~O~2~ in PBS were added to packed erythrocytes (0.06 mL). The mixture was incubated at 37 °C for 5 min. The mixture was centrifuged at 1,600 X g for 10 min. Three ml of water were added to the packed erythrocytes, and the mixture was centrifuged at 11,000 X g for 15 min. A sample buffer containing 2-mercaptoethanol was added to the residue. The samples were applied to a 7 % polyacrylamide gel and electrophoresis was carried out. The proteins in the gels were stained with Coomassie Brilliant Blue R-250.

The gel was blotted on a nitrocellulose membrane. Band 3 was stained using the band 3 antibody (ab104998, Abcam Co., UK), goat antibody to rabbit IgG (HRP activity) (ab97051) and 3, 3′, 5, 5′-tetramethylbenzidine-H~2~O~2~ solution (Ez West Blue, Atto Co., Tokyo, Japan). Oxidized proteins were stained using a protein-carbonyls detection kit (Cosmo Bio Co. Ltd., Tokyo) \[[@bib0190]\], goat antibody to rabbit IgG (111-036-144 Jackson immune Res. Lab., Inc., PA, USA) and Ez West Blue.

2.11. Statistical analyses {#sec0065}
--------------------------

Data were the mean ± SE and analyzed using Student\'s *t*-test. A difference of p \< 0.05 was considered significant.

3. Results {#sec0070}
==========

Mouse catalase activity was examined in the presence of 70 μM H~2~O~2~ at 25 °C, since the activity of the mutant catalase was deactivated at 37 °C \[[@bib0110],[@bib0115]\]. The activity in acatalasemic and normal erythrocytes at 25 °C was 1.05 ± 0.07 and 7.27 ± 0.63 μmol/s/g of hemoglobin, respectively. A two percent mouse erythrocyte suspension contained 64.5 ± 9.9 μM hemoglobin.

3.1. Percentage of hydrolysis-resistant mouse erythrocytes {#sec0075}
----------------------------------------------------------

The hydrolysis-resistant erythrocytes treated with 0--5 mM H~2~O~2~ were examined. Spontaneous hydrolysis-resistant erythrocytes in normal and acatalasemic erythrocytes were hardly detected. When erythrocytes were treated at 0.1 mM H~2~O~2~, a small percentage of hydrolysis-resistant erythrocytes was observed **(**[Table 1](#tbl0005){ref-type="table"}**)**. The amount of the resistant acatalasemic erythrocytes was higher than that in normal erythrocytes. When erythrocytes were treated at 1 mM H~2~O~2~, the hydrolysis-resistant acatalasemic erythrocytes dramatically increased to 90.1 %, but the ratio in the normal erythrocytes was 15.0 %. The effect in the hydrolysis-resistant acatalasemic erythrocytes induced by 5 mM H~2~O~2~ was ameliorated by the addition of 50 μM α-tocopherol. This suggests that the drastic increase in the hydrolysis-resistant erythrocytes is associated with changes in membrane function.Table 1Hydrolysis-resistant erythrocytes (%) in H~2~O~2~-treated mouse erythrocytes.Table 1H~2~O~2~ (mM)Vitamin ENormal mice (n≥4)Acatalasemic mice (n≥4)0.0--1.5 ± 0.91.0 ± 0.50.1--3.3 ± 3.011.5 ± 2.71.0--15.0 ± 2.590.1 ± 6.2\*5.0--14.0 ± 4.594.3 ± 10.0\*5.0+ND19.0 ± 2.7\*\*[^1]

3.2. Hemolysis of mouse erythrocytes induced by H~2~O~2~ {#sec0080}
--------------------------------------------------------

Acatalasemic mouse erythrocytes slowly exhibited hemolysis (85 ± 12 %) in the presence of 0.1 mM H~2~O~2~, and normal mouse erythrocytes did the same in 3 mM H~2~O~2~ (80 ± 5 %). This indicates that concentration of H~2~O~2~, which causes hemolysis, is associated with catalase activity.

3.3. Osmotic fragility of H~2~O~2~-treated erythrocytes {#sec0085}
-------------------------------------------------------

The osmotic fragility of H~2~O~2~-treated erythrocytes was examined to study whether the hemolysis was associated with the membrane proteins of the erythrocytes. The concentration of NaCl at 50 % hemolysis of normal erythrocytes was the same as that of acatalasemic erythrocytes in the absence of H~2~O~2~ **(**[Table 2](#tbl0010){ref-type="table"}**)**. Hypotonic hemolysis of 0.1 mM H~2~O~2~-treated acatalasemic erythrocytes was observed, but in normal erythrocytes it was observed at 5 mM H~2~O~2~. The hemolysis of the acatalasemic erythrocytes at 0.1 mM H~2~O~2~ was ameliorated by the addition of 50 μM α-tocopherol. These results suggest that hemolysis is induced by membrane fluidity changes in the erythrocytes.Table 2Sodium chloride concentration (%) at 50 % hemolysis.Table 2H~2~O~2~ (mM)Vitamin ENormal mice (n≥5)Acatalasemic mice (n≥5)0.0--0.65 ± 0.020.65 ± 0.010.1--0.67 ± 0.020.72 ± 0.01\*0.1＋0.66 ± 0.020.65 ± 0.021.0--0.67 ± 0.02ND5.0--0.71 ± 0.02\*ND[^2]

3.4. Sialic acid release from erythrocytes treated with sialidase {#sec0090}
-----------------------------------------------------------------

The sialic acid released by the administration of sialidase from 2 % acatalasemic and normal mouse erythrocytes (n = 7) was low, being 0.02 ± 0.02 and 0.01 ± 0.01 mmol / L, respectively. Upon the administration of 1 mM H~2~O~2~, the sialic acid released by sialidase from the acatalasemic erythrocytes was 0.08 ± 0.02 mmol / L, which is significantly higher than from the normal erythrocytes (0.04 ± 0.01 mmol / L). This suggests that 1 mM H~2~O~2~ induced greater damage in the membrane on acatalasemic erythrocytes than normal erythrocytes. However, as sialic acid residues on erythrocyte membrane are oxidized or depolymerized by H~2~O~2~ \[[@bib0195]\], we examined the negative charge of these erythrocytes as follows.

3.5. Alcian blue binding to erythrocytes and sialidase-treated erythrocytes {#sec0095}
---------------------------------------------------------------------------

As the binding to erythrocytes of the cationic pigment alcian blue is proportional to the negative charge on the erythrocytes, the effect of 1 mM H~2~O~2~ on the binding of the alcian blue to erythrocytes and sialidase-treated erythrocytes was examined. The binding to normal erythrocytes was almost the same as the binding to acatalasemic erythrocytes in the absence of H~2~O~2~ ([Fig. 1](#fig0005){ref-type="fig"}A). However, the pigment binding to 1 mM H~2~O~2~-treated acatalasemic mouse erythrocytes significantly decreased (23 %) compared to that (4 %) in normal erythrocytes. Alcian blue binding to sialidase-treated erythrocytes is shown in [Fig. 1](#fig0005){ref-type="fig"}B. When the sialidase-treated erythrocytes were reacted with 1 mM H~2~O~2~, the binding to both types of mouse erythrocytes significantly decreased. The decrease in binding to acatalasemic mouse erythrocytes (30 %) was larger than that in normal erythrocytes (16 %).Fig. 1Alcian blue binding to erythrocytes. (A) Control: erythrocytes were treated with PBS. H~2~O~2~: erythrocytes were treated with 1 mM H~2~O~2~. (B) Sialidase: erythrocytes were treated with sialidase; Sialidase + H~2~O~2~: sialidase-treated erythrocytes were treated with 1 mM H~2~O~2~. The binding to erythrocytes was monitored by the absorbance at 650 nm. The binding values were calculated from the absorbance compared to control alcian blue solution (100 %, A~650\ nm~ = 0.067). The numbers in parentheses indicate the number of mice used.Fig. 1

These results confirmed that the addition of 1 mM H~2~O~2~ induces potent damage on the membrane of acatalasemic erythrocytes.

3.6. Numbers of flickering erythrocytes after H~2~O~2~ treatment {#sec0100}
----------------------------------------------------------------

Erythrocyte membrane flickering is maintained by membrane proteins and an ATP mechanism \[[@bib0200],[@bib0205]\]. When acatalasemic erythrocytes were treated with 1 mM H~2~O~2~, the flickering significantly decreased (62.2 ± 6.2 %) compared to the control erythrocytes ([Fig. 2](#fig0010){ref-type="fig"}). However, in normal erythrocytes, there was no significant difference from the control erythrocytes. The decrease in acatalasemic erythrocytes may be due to suicidal erythrocyte death, eryptosis, induced by H~2~O~2~ \[[@bib0210]\].This suggests that 1 mM H~2~O~2~ induces oxidation of hemoglobin, as well as the inactivation of glycolytic enzymes and other, non-specific reactions in acatalasemic erythrocytes.Fig. 2Percentages of flickering erythrocytes in the presence of 1 mM H~2~O~2~.\* indicates P \< 0.01.Fig. 2

3.7. SDS-PAGE Analysis of membrane proteins in H~2~O~2~-treated erythrocytes {#sec0105}
----------------------------------------------------------------------------

The SDS-PAGE of line 1 (control) indicates the membrane proteins, band 1 (spectrin-α, 240 kDa), band 2 (spectrin-β, 220 kDa), band 2.1 (ankyrin, 210 kDa), band 3 (anion exchanger, 95 kDa), band 4.1 (80 kDa), band 4.2 (72 kDa) and band 5 (actin, 43 kDa) of mouse erythrocytes **(**[Fig. 3](#fig0015){ref-type="fig"}A**)**. The band 3 protein was confirmed using an antibody. In acatalasemic erythrocytes, 0.1-0.5 mM H~2~O~2~ did not affect the size or amount of the membrane proteins ([Fig. 3](#fig0015){ref-type="fig"}A right, line 2, 3). The membrane proteins (broad bands of 80--250 kDa) were faintly stained with a protein-carbonyl immunohistochemical stain ([Fig. 3](#fig0015){ref-type="fig"}B right line 2, 3). In 1 mM H~2~O~2~-treated acatalasemic erythrocytes ([Fig. 3](#fig0015){ref-type="fig"}A right line 4), the membrane proteins mostly disappeared and a new band of high molecular-weight aggregates (\>250 kDa) appeared. This suggests that the membrane proteins were converted to water-insoluble aggregates by the H~2~O~2~. In contrast, the pattern of normal erythrocytes was not affected by 0.1--1.0 mM H~2~O~2~, and a decrease in membrane-proteins was observed only at 5 mM H~2~O~2~ ([Fig. 3](#fig0015){ref-type="fig"}A left, line 1-5).Fig. 3SDS-PAGE of mouse membrane-proteins from erythrocytes treated with various concentrations of H~2~O~2~.Fig. 3

\(A\) Coomassie Brilliant Blue R-250 stain, (B) protein-carbonyl immunohistochemical stain. The left edge of the gel provides the molecular size markers. Line 1 is from erythrocytes, line 2 is from 0.1 mM H~2~O~2~ treated-erythrocytes, line 3 is from 0.5 mM H~2~O~2~, line 4 is from 1.0 mM H~2~O~2~, line 5 is from 5.0 mM H~2~O~2~.

4. Discussion {#sec0110}
=============

As erythrocytes are oxygen carriers, autoxidation of hemoglobin generates endogenous H~2~O~2~ in these cells, and the concentration of physiological H~2~O~2~ in plasma is reported to be 1--5 μM \[[@bib0010]\]. The residual catalase and hemoglobin in acatalasemic mouse erythrocytes are potent H~2~O~2~-scavengers in erythrocytes. Hydrolysis-resistant erythrocytes were hardly observed under physiological conditions, although a faint ESR signal (g = 2.005) of ferryl hemoglobin radicals, oxidized hemoglobin, was detected in the acatalasemic erythrocytes \[[@bib0125]\]. This suggests that endogenous H~2~O~2~ and the radicals were removed by cytosolic catalase and other scavenging activities in the erythrocytes. Small amounts of hydrolysis-resistant erythrocytes were detected after the addition of 0.1 mM (supra-physiological) H~2~O~2~, and the amount in the acatalasemic erythrocytes was larger than in the normal ones **(**[Table 1](#tbl0005){ref-type="table"}**)**. This may be explained by the fact that 0.1 mM H~2~O~2~ oxidizes cytosolic hemoglobin and generates hydrolysis-resistant erythrocytes, a process which is associated with the membrane rigidity induced by H~2~O~2~ *via* formation of membrane bound hemoglobin \[[@bib0130],[@bib0135]\]. Approximately 30 min after 0.1 mM H~2~O~2~ addition, hemolysis was observed in most of the acatalasemic erythrocytes, and this effect was suppressed by the addition of α-tocopherol. The 0.1 mM H~2~O~2~-treated acatalasemic erythrocytes exhibited osmotic fragility **(**[Table 2](#tbl0010){ref-type="table"}**)**. From these results, it is concluded that hemolysis was induced by membrane lipid peroxidation.

However, when the concentration of exogenous H~2~O~2~ was increased to 1 mM, the hydrolysis-resistant erythrocytes were drastically increased in the acatalasemic erythrocytes. The drastic increase was prevented by α--tocopherol, and a decrease in the water-soluble membrane proteins on SDS-PAGE was observed ([Fig. 3](#fig0015){ref-type="fig"}).These results show that 1 mM H~2~O~2~ induces a loss of membrane structure and function. The decrease of alcian blue binding to erythrocytes along with the membrane-flickering erythrocytes indicated membrane property change and disturbed metabolism, and suggested eryptosis in the erythrocytes \[[@bib0210],[@bib0215]\]. From these results, 1 mM H~2~O~2~ freely reacts with cytosolic hemoglobin to generate a high concentration of ferryl hemoglobin radicals and the aggregation reactions in turn cause the formation of hydrolysis-resistant erythrocytes. The formation of high molecular-weight aggregates in association with these changes may involve in ischemic stroke \[[@bib0220]\].

As the drastic increase of hydrolysis-resistant erythrocytes induced by supra-physiological H~2~O~2~ was associated with low catalase activity in erythrocytes, we compared the residual catalase activity in mouse acatalasemic erythrocytes with that in Japanese acatalasemic cases. Based on the published report \[[@bib0225]\], the residual catalase activity of Japanese acatalasemic erythrocytes was 0.13 % of the normal activity (at 37 °C), while the mouse residual activity at 25 °C is estimated to be 2.6 % of the human catalase activity \[[@bib0110],[@bib0115]\]. As the mouse residual catalase activity is twenty-times higher than the human activity, we suggest that the mouse residual catalase in erythrocytes has a sufficient capacity to scavenge the H~2~O~2~ induced by the infection of H~2~O~2~-generating bacteria, which will develop the onset of Takahara's disease, but the human residual catalase activity does not \[[@bib0040]\]. It may be important to recommend that acatalasemic persons take α-tocopherol since it ameliorates several oxidative stresses induced by H~2~O~2~ or alloxan administration under acatalasemic conditions \[[@bib0085], [@bib0090], [@bib0095]\].
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[^1]: ND is "not determined". \*p \< 0.01 compared to the value in normal mice. \*\*p \< 0.01 compared to the value in the absence of vitamin E.

[^2]: ND is "not determined". \*p \< 0.01 compared to the value in the absence of H~2~O~2~.
